FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4207083310> ?p ?o ?g. }

• W4207083310 endingPage "368" @default.
• W4207083310 startingPage "368" @default.
• W4207083310 abstract "Atrial fibrillation (AF), the most common arrhythmia, increases the risk of stroke.To review the evidence on screening for AF in adults without prior stroke to inform the US Preventive Services Task Force.PubMed, Cochrane Library, and trial registries through October 5, 2020; references, experts, and literature surveillance through October 31, 2021.Randomized clinical trials (RCTs) of screening among asymptomatic persons without known AF or prior stroke; test accuracy studies; RCTs of anticoagulation among persons with AF; systematic reviews; and observational studies reporting harms.Two reviewers assessed titles/abstracts, full-text articles, and study quality and extracted data; when at least 3 similar studies were available, meta-analyses were conducted.Detection of undiagnosed AF, test accuracy, mortality, stroke, stroke-related morbidity, and harms.Twenty-six studies (N = 113 784) were included. In 1 RCT (n = 28 768) of twice-daily electrocardiography (ECG) screening for 2 weeks, the likelihood of a composite end point (ischemic stroke, hemorrhagic stroke, systemic embolism, all-cause mortality, and hospitalization for bleeding) was lower in the screened group over 6.9 years (hazard ratio, 0.96 [95% CI, 0.92-1.00]; P = .045), but that study had numerous limitations. In 4 RCTs (n = 32 491), significantly more AF was detected with intermittent and continuous ECG screening compared with no screening (risk difference range, 1.0%-4.8%). Treatment with warfarin over a mean of 1.5 years in populations with clinical, mostly persistent AF was associated with fewer ischemic strokes (pooled risk ratio [RR], 0.32 [95% CI, 0.20-0.51]; 5 RCTs; n = 2415) and lower all-cause mortality (pooled RR, 0.68 [95% CI, 0.50-0.93]) compared with placebo. Treatment with direct oral anticoagulants was also associated with lower incidence of stroke (adjusted odds ratios range, 0.32-0.44) in indirect comparisons with placebo. The pooled RR for major bleeding for warfarin compared with placebo was 1.8 (95% CI, 0.85-3.7; 5 RCTs; n = 2415), and the adjusted odds ratio for major bleeding for direct oral anticoagulants compared with placebo or no treatment ranged from 1.38 to 2.21, but CIs did not exclude a null effect.Although screening can detect more cases of unknown AF, evidence regarding effects on health outcomes is limited. Anticoagulation was associated with lower risk of first stroke and mortality but with increased risk of major bleeding, although estimates for this harm are imprecise; no trials assessed benefits and harms of anticoagulation among screen-detected populations." @default.
• W4207083310 created "2022-01-26" @default.
• W4207083310 creator A5015265829 @default.
• W4207083310 creator A5021630385 @default.
• W4207083310 creator A5045175975 @default.
• W4207083310 creator A5057428854 @default.
• W4207083310 creator A5057566116 @default.
• W4207083310 creator A5070945651 @default.
• W4207083310 creator A5076399844 @default.
• W4207083310 date "2022-01-25" @default.
• W4207083310 modified "2023-10-06" @default.
• W4207083310 title "Screening for Atrial Fibrillation" @default.
• W4207083310 cites W1924098982 @default.
• W4207083310 cites W1999468381 @default.
• W4207083310 cites W2018796325 @default.
• W4207083310 cites W2019334626 @default.
• W4207083310 cites W2020061893 @default.
• W4207083310 cites W2020682484 @default.
• W4207083310 cites W2025221952 @default.
• W4207083310 cites W2027030493 @default.
• W4207083310 cites W2040452288 @default.
• W4207083310 cites W2064408156 @default.
• W4207083310 cites W2071400403 @default.
• W4207083310 cites W2073962065 @default.
• W4207083310 cites W2081669586 @default.
• W4207083310 cites W2081884170 @default.
• W4207083310 cites W2107328434 @default.
• W4207083310 cites W2118157781 @default.
• W4207083310 cites W2122355238 @default.
• W4207083310 cites W2125435699 @default.
• W4207083310 cites W2127211051 @default.
• W4207083310 cites W2161884253 @default.
• W4207083310 cites W2324403620 @default.
• W4207083310 cites W2398171321 @default.
• W4207083310 cites W2435343268 @default.
• W4207083310 cites W2465663631 @default.
• W4207083310 cites W2499224120 @default.
• W4207083310 cites W2587299378 @default.
• W4207083310 cites W2609696371 @default.
• W4207083310 cites W2752766789 @default.
• W4207083310 cites W2767853817 @default.
• W4207083310 cites W2784408897 @default.
• W4207083310 cites W2869528658 @default.
• W4207083310 cites W2887104224 @default.
• W4207083310 cites W2900570413 @default.
• W4207083310 cites W2970684805 @default.
• W4207083310 cites W2972450451 @default.
• W4207083310 cites W3002660934 @default.
• W4207083310 cites W3003299879 @default.
• W4207083310 cites W3084534158 @default.
• W4207083310 cites W3129415548 @default.
• W4207083310 cites W3196502641 @default.
• W4207083310 cites W4205645630 @default.
• W4207083310 cites W4230780842 @default.
• W4207083310 cites W4244046379 @default.
• W4207083310 cites W4245449645 @default.
• W4207083310 cites W4248511670 @default.
• W4207083310 cites W4249999102 @default.
• W4207083310 cites W4362054082 @default.
• W4207083310 doi "https://doi.org/10.1001/jama.2021.21811" @default.
• W4207083310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35076660" @default.
• W4207083310 hasPublicationYear "2022" @default.
• W4207083310 type Work @default.
• W4207083310 citedByCount "17" @default.
• W4207083310 countsByYear W42070833102022 @default.
• W4207083310 countsByYear W42070833102023 @default.
• W4207083310 crossrefType "journal-article" @default.
• W4207083310 hasAuthorship W4207083310A5015265829 @default.
• W4207083310 hasAuthorship W4207083310A5021630385 @default.
• W4207083310 hasAuthorship W4207083310A5045175975 @default.
• W4207083310 hasAuthorship W4207083310A5057428854 @default.
• W4207083310 hasAuthorship W4207083310A5057566116 @default.
• W4207083310 hasAuthorship W4207083310A5070945651 @default.
• W4207083310 hasAuthorship W4207083310A5076399844 @default.
• W4207083310 hasBestOaLocation W42070833101 @default.
• W4207083310 hasConcept C126322002 @default.
• W4207083310 hasConcept C127413603 @default.
• W4207083310 hasConcept C164705383 @default.
• W4207083310 hasConcept C168563851 @default.
• W4207083310 hasConcept C1862650 @default.
• W4207083310 hasConcept C194828623 @default.
• W4207083310 hasConcept C207103383 @default.
• W4207083310 hasConcept C23131810 @default.
• W4207083310 hasConcept C2776301958 @default.
• W4207083310 hasConcept C2776478404 @default.
• W4207083310 hasConcept C2777910003 @default.
• W4207083310 hasConcept C2779161974 @default.
• W4207083310 hasConcept C2780645631 @default.
• W4207083310 hasConcept C44249647 @default.
• W4207083310 hasConcept C71924100 @default.
• W4207083310 hasConcept C78519656 @default.
• W4207083310 hasConceptScore W4207083310C126322002 @default.
• W4207083310 hasConceptScore W4207083310C127413603 @default.
• W4207083310 hasConceptScore W4207083310C164705383 @default.
• W4207083310 hasConceptScore W4207083310C168563851 @default.
• W4207083310 hasConceptScore W4207083310C1862650 @default.
• W4207083310 hasConceptScore W4207083310C194828623 @default.
• W4207083310 hasConceptScore W4207083310C207103383 @default.

• next